A new UK study has raised concerns that the CCP virus has more chance to mutate during chronic infections, and it could “mutate to outwit our vaccines,” a leader of the study said.
In an unedited manuscript pre-published by Nature on Friday, a team led by researchers at Cambridge University said they saw repeated mutations while treating an immunocompromised patient.